《WHO基本药物示范目录》中抗肿瘤药物的变化及对我国《国家基本药物目录》修订的启示
闫加庆, 刘敏, 马颖林, 乐凯迪, 董斌, 李国辉
Analysis on changes in anti-tumor drug in WHO essential model list and the effect on revision of national essential medicines list
YAN Jia-qing, LIU Min, MA Ying-lin, LE Kai-di, DONG Bin, LI Guo-hui
临床药物治疗杂志
.
2021, (4): 54
-57
.
DOI: 10.3969/j.issn.1672-3384.2021.04.011
